Abstract
The annual Papanicolaou smear as a screening test for cervical cancer is evaluated on the basis of cost-effectiveness, predictive value, and other factors of patient selection and comparative trends in mortality rate before and after the introduction of screening programs. For the asymptomatic woman at normal risk for cancer, Papanicolaou smears are recommended only once every five years, although symptomatic or high-risk women should still maintain an annual screening schedule.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
